Showing 1 - 5 results of 5 for search 'Sivahari Prasad Gorantla', query time: 0.03s
Refine Results
-
1
-
2
A newly identified 45‐kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance by Sivahari Prasad Gorantla, Tony Andreas Mueller, Corinna Albers‐Leischner, Martina Rudelius, Nikolas vonBubnoff, Justus Duyster
Published 2024-02-01
Article -
3
NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis by Stefanie Kreutmair, Stefanie Kreutmair, Lena Johanna Lippert, Lena Johanna Lippert, Cathrin Klingeberg, Corinna Albers-Leischner, Corinna Albers-Leischner, Salome Yacob, Valeria Shlyakhto, Tony Mueller, Tony Mueller, Alina Mueller-Rudorf, Chuanjiang Yu, Sivahari Prasad Gorantla, Sivahari Prasad Gorantla, Cornelius Miething, Cornelius Miething, Justus Duyster, Justus Duyster, Anna Lena Illert, Anna Lena Illert
Published 2022-05-01
Article -
4
Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells by Vijay Kumar Boddu, Piet Zamzow, Mario Wolfgang Kramer, Axel S. Merseburger, Sivahari Prasad Gorantla, Matthias Klinger, Lena Cramer, Thorben Sauer, Timo Gemoll, Nikolas von Bubnoff, Frank Gieseler, Masoud Darabi
Published 2024-02-01
Article -
5
Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response by Rüdiger Braun, Olha Lapshyna, Jessica Watzelt, Maren Drenckhan, Axel Künstner, Benedikt Färber, Ahmed Ahmed Mohammed Hael, Louisa Bolm, Kim Christin Honselmann, Björn Konukiewitz, Darko Castven, Malte Spielmann, Sivahari Prasad Gorantla, Hauke Busch, Jens-Uwe Marquardt, Tobias Keck, Ulrich Friedrich Wellner, Hendrik Ungefroren
Published 2023-02-01
Article